Phelan-McDermid Syndrome (PMS), also known as 22q13 deletion syndrome, is a rare genetic disorder caused by the deletion or loss of a portion of chromosome 22. Life expectancy in individuals with PMS can vary depending on the severity of symptoms and associated medical complications. However, there is limited research available on life expectancy specifically related to PMS.
Despite the lack of specific data, individuals with PMS are at a higher risk for infections, seizures, and respiratory complications, which may impact life expectancy. Additionally, some individuals with PMS may have intellectual disability, delayed development, and difficulties with communication and socialization, which can affect quality of life as well.
It is important to note that every individual with PMS is unique, and life expectancy cannot be accurately predicted based on the diagnosis alone without taking into consideration other factors such as overall health and medical history. Regular medical care and monitoring can help manage symptoms and improve outcomes for individuals with PMS.
Ne Demek sitesindeki bilgiler kullanıcılar vasıtasıyla veya otomatik oluşturulmuştur. Buradaki bilgilerin doğru olduğu garanti edilmez. Düzeltilmesi gereken bilgi olduğunu düşünüyorsanız bizimle iletişime geçiniz. Her türlü görüş, destek ve önerileriniz için iletisim@nedemek.page